Yanguanjia HA And NA Series Breath Analyzer

Portable breath analyzer for non-invasive detection and measurement of volatile organic compounds and biomarkers in exhaled breath. Applicable in respiratory diagnostics, metabolic screening, and point-of-care testing environments. Provides rapid analysis with minimal patient preparation required.

The WLD801 is a non-invasive analyzer that measures exhaled nitric oxide (FeNO) levels to assess airway inflammation in respiratory conditions such as asthma and allergic rhinitis. It provides rapid, objective diagnostic support for clinicians in pulmonology and allergy departments. The device delivers quantitative results with high sensitivity and specificity for patient management.

A diagnostic device for measuring nitric oxide (NO) levels in exhaled breath, available in models Reslink R100 and Reslink R200. It has a measurement range of 1-3500ppb and is a Class II medical device certified by China's NMPA. The device is used for assisting in the diagnosis and assessment of conditions such as asthma and chronic obstructive pulmonary disease, as well as for monitoring disease progression.

A wearable device that performs laboratory-level analysis of biomarkers in breath samples in near-real-time. Based on headspace gas chromatography technology, it enables on-site measurement of metabolic markers including fat combustion indicators. Developed through 15+ years of research at ETH Zurich.

A high-precision nitric oxide (NO) measurement device designed for detecting NO and non-oxygen carbon dioxide in exhaled gas. The eNoglow series includes models LN1000, LN2000, LN3000, and LN4000, with a measurement range of 0-5000ppb and a resolution of 0.01ppb. It is a Class II medical device registered with China's NMPA and designed to meet the high standards required in clinical settings such as pediatrics, cardiology, and intensive care units.

A compact breath analysis device that detects volatile sulfur compounds (VSCs) in human exhalation to assess periodontal disease risk. The device measures VSC emissions and pH levels, providing quantitative data for early detection of oral health conditions.

Carbon-13 breath test analyzer for non-invasive diagnosis of gastrointestinal disorders including H. pylori infection, small intestinal bacterial overgrowth, and lactose malabsorption. The device measures exhaled carbon-13 levels to assess metabolic function and intestinal health with rapid turnaround times.

A portable exhaled carbon dioxide (CO2) measurement device using non-dispersive infrared (NDIR) technology, available in models etCOlink C100 and etCOlink C200. It has a measurement range of 0-100ppm and is a Class II medical device registered with China's NMPA. Users can perform testing activities through a human-computer interface, making it suitable for clinical applications including respiratory disease diagnosis, treatment effect evaluation, and hemoglobin monitoring.

FANas is a non-invasive diagnostic analyzer for 13C and H2 breath testing, designed to detect Helicobacter pylori, lactose intolerance, and gastric emptying disorders. The portable monitor measures exhaled hydrogen levels in ppm and offers data storage, PC transfer, and customizable test protocols with clinical research guidance and laboratory information system integration.

A compact smart breath analyzer that detects volatile sulfur compounds (VSCs) in human and pet exhalation to identify early signs of periodontal disease and measure pH levels. Using AI algorithms, the device transforms raw data into risk evaluations for remote monitoring services. The device is non-invasive, easy to use, and allows users to collect vital data anytime, anywhere.

Non-invasive point-of-care assessment device for airway inflammation that combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results including FeNO, CaNO, and FnNO in under one minute, with a patented dual-channel design that ensures complete protection against cross-contamination.

Nanoparticle-based exhaled breath analysis system for disease screening and biomarker detection. Enables non-invasive respiratory and systemic disease evaluation. Integrated analysis algorithms for automated interpretation.